IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 141 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.41 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $515,226 | +67.0% | 84,325 | +69.5% | 0.00% | 0.0% |
| Q4 2022 | $308,444 | -70.8% | 49,749 | +46.2% | 0.00% | -50.0% |
| Q1 2021 | $1,058,000 | -41.7% | 34,022 | -13.0% | 0.00% | -33.3% |
| Q4 2020 | $1,814,000 | +83.8% | 39,099 | +28.6% | 0.00% | +50.0% |
| Q3 2020 | $987,000 | -67.2% | 30,410 | -72.3% | 0.00% | -60.0% |
| Q2 2020 | $3,011,000 | +49.7% | 109,702 | +63.2% | 0.01% | +66.7% |
| Q1 2020 | $2,012,000 | +69.6% | 67,213 | +56.8% | 0.00% | +200.0% |
| Q4 2019 | $1,186,000 | +158.4% | 42,852 | +70.1% | 0.00% | 0.0% |
| Q3 2019 | $459,000 | +54.5% | 25,197 | -24.9% | 0.00% | – |
| Q4 2018 | $297,000 | -43.4% | 33,573 | -28.1% | 0.00% | -100.0% |
| Q3 2018 | $525,000 | +4.2% | 46,692 | +18.5% | 0.00% | 0.0% |
| Q2 2018 | $504,000 | – | 39,399 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 565,890 | $26,257,000 | 9.39% |
| Consonance Capital Management LP | 1,710,803 | $79,381,000 | 7.41% |
| GREAT POINT PARTNERS LLC | 917,427 | $42,569,000 | 6.91% |
| Avoro Capital Advisors LLC | 7,500,000 | $348,000,000 | 5.99% |
| Ghost Tree Capital, LLC | 500,000 | $23,200,000 | 5.17% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $60,923,000 | 4.69% |
| Perceptive Advisors | 9,166,304 | $425,316,000 | 4.56% |
| Ally Bridge Group (NY) LLC | 360,000 | $16,704,000 | 2.86% |
| Orbimed Advisors | 6,645,100 | $308,333,000 | 2.70% |
| ACUTA CAPITAL PARTNERS, LLC | 164,800 | $7,647,000 | 2.08% |